<sentence id="0">Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic , the first recognized endoplasmic reticulum defect in N-glycan synthesis .</sentence>
<sentence id="1">We report on 8 patients with a recently described novel subtype of congenital disorder of glycosylation type Ic ( CDG-Ic ) .</sentence>
<sentence id="2">Their clinical presentation was mainly neurological with developmental retardation , muscular hypotonia , and epilepsy .</sentence>
<sentence id="3">Several symptoms commonly seen in CDG-Ia such as <scope type="neg" id="0">inverted nipples , abnormal fat distribution , and cerebellar hypoplasia were <cue type="neg" id="0">not</cue> observed</scope> .</sentence>
<sentence id="4">The clinical course is milder overall , with a better neurological outcome , than in CDG-Ia .</sentence>
<sentence id="5">The isoelectric focusing pattern of serum transferrin in CDG-Ia and CDG-Ic is indistinguishable .</sentence>
<sentence id="6">Interestingly , beta-trace protein in cerebrospinal fluid derived from immunoblot analysis of the brain showed a less pronounced hypoglycosylation pattern in CDG-Ic patients than in CDG-Ia patients .</sentence>
<sentence id="7">Analysis of lipid-linked oligosaccharides revealed an accumulation of Man9GlcNAc2 intermediates due to dolichol pyrophosphate-Man9GlcNAc2 alpha-1,3 glucosyltransferase deficiency .</sentence>
<sentence id="8">All patients were homozygous for an A333V mutation .</sentence>